Literature DB >> 24592637

Sleep apnoea and its relationship with cardiovascular, pulmonary, metabolic and other morbidities.

F Khan1, C Walsh2, S J Lane2, E Moloney2.   

Abstract

Sleep apnoea (OSAS) is a multisystem disorder. There is a high prevalence of cardiovascular and metabolic morbidities in patients investigated for sleep apnoea. We aim to evaluate any association between cardiovascular, metabolic and pulmonary co morbidities in patients investigated for OSAS and whether clinical findings based on Epworth sleep score (ESS) and snoring helps in diagnosing sleep apnoea. 258 consecutive patients who were electively admitted for sleep assessment in Peamount Hospital, Dublin from Sept 2009 to Aug 2011 were retrospectively reviewed. 139/258 were diagnosed as OSAS. Cardiovascular, metabolic and pulmonary co morbidities were 46.12%, 37.2% and 29% respectively. There is no correlation found between ESS, Snoring with Apnoea Hypopnoea Index in OSAS group. Screening for OSAS should be considered in patients with certain cardiovascular and metabolic disorders. PSG is so far considered the gold standard investigation to diagnose OSAS and better clinical evaluating tools need to be formulated.

Entities:  

Mesh:

Year:  2014        PMID: 24592637

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  3 in total

1.  Bone mineral density and changes in bone metabolism in patients with obstructive sleep apnea syndrome.

Authors:  Rabia Terzi; Zahide Yılmaz
Journal:  J Bone Miner Metab       Date:  2015-07-24       Impact factor: 2.626

2.  Adiponectin ameliorates lung injury induced by intermittent hypoxia through inhibition of ROS-associated pulmonary cell apoptosis.

Authors:  Wenxiao Ding; Xilong Zhang; Qiang Zhang; Yanbin Dong; Wenjing Wang; Ning Ding
Journal:  Sleep Breath       Date:  2020-05-26       Impact factor: 2.816

3.  Drug-induced sleep endoscopy as a selection tool for mandibular advancement therapy by oral device in patients with mild to moderate obstructive sleep apnoea.

Authors:  E De Corso; G Bastanza; G Della Marca; C Grippaudo; G Rizzotto; M R Marchese; A Fiorita; B Sergi; D Meucci; W Di Nardo; G Paludetti; E Scarano
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.